Ramsay L, Mackay A, Eppel M, Oliver J
Br J Clin Pharmacol. 1980; 10(2):101-7.
PMID: 7426271
PMC: 1430045.
DOI: 10.1111/j.1365-2125.1980.tb01725.x.
Halkin H, Mazar A, Almog S, Schnaps Y
Eur J Clin Pharmacol. 1982; 23(3):225-8.
PMID: 7173293
DOI: 10.1007/BF00547558.
Lagas M, Jonkman J
Eur J Clin Pharmacol. 1983; 24(6):761-7.
PMID: 6884413
DOI: 10.1007/BF00607084.
Crombeen J, de Blaey C
Pharm Weekbl Sci. 1983; 5(2):65-9.
PMID: 6866717
DOI: 10.1007/BF01960078.
Horai Y, Ishizaki T, Sasaki T, Chiba K, Suganuma T, Echizen H
Eur J Clin Pharmacol. 1983; 24(1):79-87.
PMID: 6832206
DOI: 10.1007/BF00613931.
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.
Hendeles L, Iafrate R, Weinberger M
Clin Pharmacokinet. 1984; 9(2):95-135.
PMID: 6370542
DOI: 10.2165/00003088-198409020-00001.
New method for bioavailability assessment of slow-release preparations of theophylline.
Kasuya Y, Ohno T, Kubota N, Takahashi H, Hirayama H
J Pharmacokinet Biopharm. 1985; 13(6):571-87.
PMID: 3834072
DOI: 10.1007/BF01058902.
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.
Pagliaro L, Benet L
J Pharmacokinet Biopharm. 1975; 3(5):333-83.
PMID: 1107513
DOI: 10.1007/BF01082306.
The efficacy of Neo-Biphyllin Retard in asthmatic patients--a theophylline slow-releasing coated tablet.
Albrecht H, Messerli C, Scherrer M
Pneumonologie. 1976; 153(3):177-84.
PMID: 785410
DOI: 10.1007/BF02095883.
Clinical pharmacokinetics of theophylline.
OGILVIE R
Clin Pharmacokinet. 1978; 3(4):267-93.
PMID: 354635
DOI: 10.2165/00003088-197803040-00002.
